Cutaneous Side Effects of First-Second Line Oral Disease - Modifying Treatments in Patients with Multiple Sclerosis


Arslan D., Tuncer M. A.

Journal of Experimental Neurology, cilt.2020, sa.1, ss.152-157, 2020 (Hakemli Dergi)